Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

Aethlon Medical (NASDAQ:AEMD) and Avicanna (OTC:AVCNF) among companies presenting

Mar. 13, 2026 at 12:35pm

Virtual Investor Conferences, the leading proprietary investor conference series, announced that presentations from the Life Sciences Virtual Investor Forum, held March 11th – 12th, are now available for on-demand viewing. The forum featured CEO chats and company presentations from leadership teams representing innovative companies across the biotechnology, medical device, and pharmaceutical sectors.

Why it matters

The Life Sciences Virtual Investor Forum provides a platform for publicly traded companies in the life sciences industry to showcase their technologies, initiatives, and growth opportunities directly to investors. This allows investors to gain insights into emerging trends and investment opportunities within the sector.

The details

The presentations will be available 24/7 for 90 days, and investors, advisors, and analysts may download investor materials from the companies' resource sections. Select companies are also accepting 1x1 management meeting requests through March 17th.

  • The Life Sciences Virtual Investor Forum was held on March 11th – 12th, 2026.
  • The presentations will be available for on-demand viewing for 90 days starting on March 13th, 2026.

The players

Virtual Investor Conferences

The leading proprietary investor conference series that provides an interactive forum for publicly traded companies to present directly to investors.

Aethlon Medical

A NASDAQ-listed biotechnology company that presented at the Life Sciences Virtual Investor Forum.

Avicanna

An OTC-listed pharmaceutical company that presented at the Life Sciences Virtual Investor Forum.

Got photos? Submit your photos here. ›

What’s next

Investors, advisors, and analysts can schedule 1x1 management meetings with select companies through March 17th, 2026.

The takeaway

The Life Sciences Virtual Investor Forum provides a valuable opportunity for investors to gain insights into emerging technologies, strategic initiatives, and growth opportunities within the life sciences industry by directly engaging with the leadership teams of publicly traded companies in the sector.